|
Proto-Oncogene Proteins c-bcl-2
|
D12.776.624.664.700.169 |
|
|
Adenovirus E1A Proteins
|
D12.776.930.100 |
|
|
Irbesartan
|
D04.711.431 |
|
|
Neurofibrosarcoma
|
C04.557.450.565.590.350.590 |
|
|
Fibrosarcoma
|
C04.557.450.565.590.350 |
|
|
Pre-B-Cell Leukemia Transcription Factor 1
|
D12.776.624.664.700.163 |
|
|
Troponin T
|
D05.750.078.730.825.962 |
|
|
Terminator Regions, Genetic
|
G05.360.080.689.810 |
|
|
Interferon Regulatory Factor-1
|
D12.776.476.024.385.124 |
|
|
Erythrocyte Count
|
E05.242.195.107.330 |
|
|
AIDS-Related Opportunistic Infections
|
C20.673.480.100 |
|
|
Orthodontic Retainers
|
E06.658.453.637 |
|
|
Zeaxanthins
|
D065146 |
[Carotenoids found in fruits and vegetables. Zeaxanthin accumulates in the MACULA LUTEA.
] |
|
Proton-Phosphate Symporters
|
D12.776.543.585.450.074.750.500 |
|
|
Viral Fusion Protein Inhibitors
|
D065147 |
[Drugs that are designed to block the action of VIRAL FUSION PROTEINS and prevent VIRUSES from entering the cell.
] |
|
Uronic Acids
|
D02.241.081.844.915 |
|
|
Sugar Acids
|
D02.241.081.844 |
|
|
Nicolau Syndrome
|
D065148 |
[An uncommon complication of INTRAMUSCULAR INJECTION leading to variable degrees of necrosis of skin and underlying tissue.
] |
|
MutS Homolog 2 Protein
|
D12.776.624.664.700.130 |
|
|
Cell Wall Skeleton
|
D12.776.395.560.186 |
|
